GL1X · GenesisL1 explorer

MolNFT v1 · #172098 · protein

17BETA-hydroxysteroid dehydrogenase type 14 variant S205 in complex with non-steroidal inhibitor

6ZR6 · 17-beta-hydroxysteroid dehydrogenase 14: “17BETA-hydroxysteroid dehydrogenase type 14 variant S205 in complex with non-steroidal inhibitor”. X-ray diffraction, 4 ligands (NAD, F45, BGC), 1 pocket (best druggability 0.75). MolNFT v1…

PDB
6ZR6
Type
protein
Length
257 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
17-beta-hydroxysteroid dehydrogenase 14
EC
1.1.1.-
UniProt
Q9BPX1
Ligands
NAD, F45, BGC, NA
Pockets
1 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A17-beta-hydroxysteroid dehydrogenase 14 (EC 1.1.1.-)protein25750% helix, 15% strandQ9BPX1

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • F45 · [6-(3,4-dihydroxyphenyl)pyridin-2-yl](4-fluoro-3-hydroxyphenyl)methanone · ligand · chains A
  • BGC · beta-D-glucopyranose · sugar · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16060.750.8261NAD, F45

Compared structures

  • 6ZR6 · 17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with non-steroidal… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9BPX1 · AlphaFold monomer V2.0 prediction for 17-beta-hydroxysteroid dehydrogenase 14 (Q9BPX1) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.